Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
6 participants
INTERVENTIONAL
2018-03-30
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Visual Retraining After Stroke
NCT06121219
Factors in Learning And Plasticity: Healthy Vision
NCT05439759
Examining the Effect of Eye Gaze Technology on Children With Cortical Visual Impairment
NCT06067607
Visual Stimulus Competition
NCT03741595
Virtual Reality Mobility Training System for Veterans With Vision Loss
NCT00333879
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training Group
Spatial training
Spatial Training
Spatial Training using a 5x5 grid
Control Group
Letter number matching
Letter number matching
Letter number matching
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spatial Training
Spatial Training using a 5x5 grid
Letter number matching
Letter number matching
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The investigators anticipate that causes of blindness will be ocular, including:
* glaucoma
* diabetic retinopathy and macular degeneration
* the most common causes of blindness in Veterans
* as well as possibly late-onset Leber's optic atrophy and ocular trauma (in the absence of TBI)
* To minimize heterogeneity due to variations in age and the duration of visual loss, the investigators will restrict enrollment to Veterans and Non-Veterans over the age of 50 who lost light perception within the last 5 years, and who have completed standard O\&M training.
* From a practical standpoint, this also enables the investigators to focus on participants who can potentially benefit most from the proposed intervention.
Exclusion Criteria
* TBI
* history of blast exposure
* stroke
* brain tumors
* epilepsy, etc.
* Participants will also be excluded if MRI scanning is contra-indicated, e.g.:
* due to an implanted device such as a pacemaker
* or foreign bodies of ferromagnetic nature
* Cognitive screening will be performed using the Repeatable Battery for Assessment of Neuropsychological Status (RBANS, Randolph, 1998) and participants with cognitive impairment will be excluded based on a score of 1.5 SD below the mean for the Verbal Memory Index.
* The investigators will test participants' hearing using a validated screening questionnaire (Screening Version of the Hearing Handicap Inventory for the Elderly, HHIE-S, Wentry \& Weinstein, 1983, Lichtenstein et al., 1988) followed by assessment of audiometric pure tone (0.5, 1.0, 2.0, 4.0 KHz) hearing thresholds in the CVNR sound booth.
* Participants with more than mild hearing loss (HHIE score \>8 or audiometric thresholds \>40dB) will be excluded (Wentry \& Weinstein, 1983; Wilson, 2009), given that the investigators are relying on audio cues.
* The investigators will also exclude visually impaired Veterans who are dependent on a wheelchair or scooter for mobility, as they will not be able to take part in the real-world task.
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
April Y. Maa, MD BS
Role: PRINCIPAL_INVESTIGATOR
Atlanta VA Medical and Rehab Center, Decatur, GA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emory University
Atlanta, Georgia, United States
Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C2243-P
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.